PropertyValue
?:abstract
  • One of the objectives that the scientific community is setting itself is to understand whether acquired immunity and the presence of antibodies against acute coronavirus 2 (SARS-CoV-2) antibodies protect against reinfection. Although there are many published papers describing how the re-positivization of nasopharyngeal swab polymerase chain reaction real time (RT-PCR) test and clinical healing of the subject can be justified by numerous reasons and random situations. Our aim is to highlight how there are certain populations more susceptible to re-infection than others. This article is protected by copyright. All rights reserved.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1002/jmv.26701
?:journal
  • J_Med_Virol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/2636365763222f4834438494abe0af57753ebc2c.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7753699.xml.json
?:pmcid
?:pmid
?:pmid
  • 33247596.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Recurrent COVID‐19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?
?:type
?:year
  • 2020-12-17

Metadata

Anon_0  
expand all